In aggressive WiDr cells carrying <i>TP53</i> R273H mutation, knockout of <i>UGCG</i> gene using CRISPR/Cas9 editing or inhibition of GCS with Genz-161 sensitized cancer cells to oxaliplatin, irinotecan and paclitaxel. Here, TP53 is linked to cancer.